Pablo Garcia Valtanen

Dr. Pablo Garcia Valtanen

Clinical and Health Sciences Division, University of South Australia, Adelaide SA 5001 Australia
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2013 in Proceedings Of The Royal Society B-Biological Sciences
Verified
Journal Article
Open access
SBSebastian Boltana
Sebastian Boltana
SPSonia Rey Planellas
Sonia Rey Planellas
NRNerea Roher
Nerea Roher
RVReynaldo Vargas
Reynaldo Vargas
MHMario Huerta
Mario Huerta
SMS. MacKenzie
S. MacKenzie
Behavioural fever, defined as an acute change in thermal preference driven by pathogen recognition, has been reported in a variety of invertebrates and ectothermic vertebrates. It has been suggested, but so far not confirmed, that such changes in thermal regime favour the immune response and thus promote survival. Here, we show that zebrafish display behavioural fever that acts to promote extensive and highly specific temperature-dependent changes in the brain transcriptome. The observed coupling of the immune response to fever acts at the gene–environment level to promote a robust, highly specific time-dependent anti-viral response that, under viral infection, increases survival. Fish that are not offered a choice of temperatures and that therefore cannot express behavioural fever show decreased survival under viral challenge. This phenomenon provides an underlying explanation for the varied functional responses observed during systemic fever. Given the effects of behavioural fever on survival and the fact that it exists across considerable phylogenetic space, such immunity–environment interactions are likely to be under strong positive selection.

14 March 2017 in Immunology & Cell Biology
Verified
Journal Article
Open access
PVPablo Garcia Valtanen
Pablo Garcia Valtanen
RGRuth Marian Guzman‐Genuino
Ruth Marian Guzman‐Genuino
DWDavid L Williams
David L Williams
JHJohn Hayball
John Hayball
KDKerrilyn R Diener
Kerrilyn R Diener
The β‐1, 3 (d)‐glucan (β‐glucan) present in the cell wall of Candida albicans induces epigenetic changes in human monocytes resulting in primed macrophages exhibiting increased cytokine responsiveness to reinfection. This phenomenon is referred to as trained immunity or innate immune memory. However, whether β‐glucan can reprogramme murine monocytes in vitro or induce lasting effects in vivo has yet to be elucidated. Thus, purified murine spleen‐derived monocytes were primed with β‐glucan in vitro and assessed for markers of differentiation and survival. Important macrophage cell markers during monocyte‐to‐macrophage differentiation were downregulated and survival enhanced due to partial inhibition of apoptosis. Increased survival and not the β‐glucan training effect explained the elevated production of tumour necrosis factor‐α (TNFα) and interleukin‐6 (IL‐6) induced by subsequent lipopolysaccharide (LPS) challenge. In vivo, 4 days after systemic administration of β‐glucan, mice were more responsive to LPS challenge as shown by the increased serum levels of TNFα, IL‐6 and IL‐10, an effect shown to be short lived as enhanced cytokine production was lost by day 20. Here, we have characterised murine macrophages derived from β‐glucan‐primed monocytes based on their surface marker expression and for the first time provide evidence that the training effect of β‐glucan in vivo declines within a 3‐week period.

1 January 2014 in Antiviral Research
Verified
Journal Article
Closed access
PVPablo Garcia Valtanen
Pablo Garcia Valtanen
AMA. Martinez-Lopez
A. Martinez-Lopez
MOMaria del Mar Ortega-Villaizan
Maria del Mar Ortega-Villaizan
LPL. Perez
L. Perez
JMJulio Morales
Julio Morales
AEAmparo Estepa
Amparo Estepa

16 July 2014 in Autophagy
Verified
Journal Article
Open access
PVPablo Garcia Valtanen
Pablo Garcia Valtanen
MOMaria del Mar Ortega-Villaizan
Maria del Mar Ortega-Villaizan
AMAlicia Martínez-López
Alicia Martínez-López
RGRegla María Medina Gali
Regla María Medina Gali
LPLuis Perez
Luis Perez
AEAmparo Estepa
Amparo Estepa
It has not been elucidated whether or not autophagy is induced by rhabdoviral G glycoproteins (G) in vertebrate organisms for which rhabdovirus infection is lethal. Our work provides the first evid...

1 June 2014 in Vaccine
Verified
Journal Article
Open access
ARAngels Ruyra
Angels Ruyra
MCMary Cano
Mary Cano
PVPablo Garcia Valtanen
Pablo Garcia Valtanen
DYDaniel Yero
Daniel Yero
IGIsidre Gibert
Isidre Gibert
NRNerea Roher
Nerea Roher
Herein we report the use of immunostimulant-loaded nanoliposomes (called NLcliposomes) as a strategy to protect fish against bacterial and/or viral infections. This work entailed developing a method for in vivo tracking of the liposomes administered to adult zebrafish that enables evaluation of their in vivo dynamics and characterisation of their tissue distribution. The NLc liposomes, which co-encapsulate poly(I:C) and LPS, accumulate in immune tissues and in immunologically relevant cells such as macrophages, as has been assessed in trout primary cell cultures. They protect zebrafish against otherwise lethal bacterial (Pseudomonas aeruginosa PAO1) and viral (Spring Viraemia of Carp Virus) infections regardless of whether they are administered by injection or by immersion, as demonstrated in a series of in vivo infection experiments with adult zebrafish. Importantly, protection was not achieved in fish that had been treated with empty liposomes or with a mixture of the free immunostimulants. Our findings indicate that stimulation of the innate immune system with co-encapsulated immunostimulants in nano-liposomes is a promising strategy to simultaneously improve the levels of protection against bacterial and viral infections in fish.

1 October 2016 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
Vicente GalianoVicente Galiano
Vicente Galiano
PVPablo Garcia Valtanen
Pablo Garcia Valtanen
Vicente MicolVicente Micol
Vicente Micol
JEJosé Antonio Encinar
José Antonio Encinar
The dengue virus (DENV) nonstructural protein 5 (NS5) contains both an N-terminal methyltransferase domain and a C-terminal RNA-dependent RNA polymerase domain. Polymerase activity is responsible for viral RNA synthesis by a de novo initiation mechanism and represents an attractive target for antiviral therapy. The incidence of DENV has grown rapidly and it is now estimated that half of the human population is at risk of becoming infected with this virus. Despite this, there are no effective drugs to treat DENV infections. The present in silico study aimed at finding new inhibitors of the NS5 RNA-dependent RNA polymerase of the four serotypes of DENV. We used a chemical library comprising 372,792 nonnucleotide compounds (around 325,319 natural compounds) to perform molecular docking experiments against a binding site of the RNA template tunnel of the virus polymerase. Compounds with high negative free energy variation (ΔG <-10.5 kcal/mol) were selected as putative inhibitors. Additional filters for favorable druggability and good absorption, distribution, metabolism, excretion, and toxicity were applied. Finally, after the screening process was completed, we identified 39 compounds as lead DENV polymerase inhibitor candidates. Potentially, these compounds could act as efficient DENV polymerase inhibitors in vitro and in vivo.